Financial Services · NSE: POLICYBZR · BSE: 543390
PB Fintech: how the business works
PB Fintech runs Policybazaar, where people compare and buy insurance, and Paisabazaar, for loans and credit cards; insurers and lenders paid it ₹6,794 crore in FY26.
Follow PB Fintech
Email me when PB Fintech's page is updated after results.
We store your email address with Kit, our email provider, which also records when you sign up and whether you open or click our emails. We send a confirmation email first. See our privacy policy.
PB Fintech Ltd · Gurugram, Haryana · Founded 2008
Updated for Q2 FY27 · checked
- Revenue, FY26
- ₹6,794 cr
- Profit, FY26
- ₹670 cr
- Insurance premium placed, FY26 (company measure, without GST)
- ₹29,934 cr
- Incorporated
- 2008
- Promoter holding, Sep 2026
- None (no promoter)
The short version
PB Fintech in 5 points
1 · What it sells
PB Fintech runs Policybazaar, through which ₹29,934 crore of insurance premium (without GST, company measure) was placed in FY26, and Paisabazaar, a marketplace for loans and credit cards.
2 · Who pays it
In FY26 insurance broking, paid for by insurers as commissions, brought in 89.6% of PB Fintech's revenue, and other services such as loans and credit cards for lenders 10.4%.
3 · What it keeps from ₹100
Of every ₹100 that came in during FY26, PB Fintech kept ₹9.4 as profit, with ₹5.2 of the ₹100 coming from other income outside its operations, and its EBITDA, which leaves other income out, was ₹7.5 per ₹100 of revenue.
4 · Where the operating profit comes from
PB Fintech's insurance broking segment made ₹860.8 crore before interest and tax in FY26, while its other services segment, which includes Paisabazaar, lost ₹116.3 crore.
5 · The one thing to watch
IRDAI's Sep 2026 consultation paper proposes new commission limits, and management estimated on 24 Sep 2026 that, under the draft as proposed, PB Fintech's general insurance revenue in net-present-value terms would be one-third to 40% of the level at that time.
Sources: From PB Fintech's FY26 annual report, its Q4 FY26 results and presentation, its 24 Sep 2026 analyst call and IRDAI-related exchange filing · checked
Sources (5)
- Q4 FY26 board outcome: results, press release and shareholder presentation
- Integrated Annual Report FY26 (2025-26), incl. consolidated financial statements and BRSR
- Q4 FY26 and FY26 consolidated results (Integrated Filing XBRL)
- Clarification on price movement: IRDAI consultation paper on the economics of insurance distribution
- Transcript of analyst and investor call on the IRDAI consultation paper (call 24 Sep 2026)
01Where the money goes · FY26
Where does ₹100 of PB Fintech's money go?
PB Fintech · FY26
Receipt for every ₹100
| Employees | ₹34.4 |
|---|---|
| Agent commissions | ₹27.0 |
| Advertising | ₹16.9 |
| Internet and other costs | ₹9.4 |
| Depreciation and lease interest | ₹2.4 |
| Income tax | ₹0.5 |
| Kept as profit | ₹9.4 |
| Total | ₹100 |
Each line = amount ÷ total money in × 100. Lines may not add to exactly ₹100 because of rounding.
How this is worked out
Of every ₹100 that came in during FY26: revenue (₹6,794.0 crore) plus other income (₹372.4 crore), ₹7,166.4 crore in all; other income was ₹5.2 of each ₹100. Cityfort calculation: each line ÷ ₹7,166.4 crore × 100, from the FY26 annual report (S1). Profit per ₹100 of revenue alone was ₹9.9.
Save this receipt as an image
Embed this receipt or the key numbers
Paste this code into a blog or website to show the card you choose, with a link back to this page.
Each week: the next company due to report results, explained in 5 points.
We'll email you once a week with what changed on Cityfort. Facts only, no tips. Unsubscribe any time.
We store your email address with Kit, our email provider, which also records when you sign up and whether you open or click our emails. We send a confirmation email first. See our privacy policy.
02The business in one line
What does PB Fintech do?
Insurers and lenders pay PB Fintech commissions and fees for the customers it brings them; most of that money goes on staff, agent payouts and advertising, and what's left is profit.
- In FY26 insurance broking brought in ₹6,089 crore of PB Fintech's ₹6,794 crore revenue; loan, card and other services brought in ₹705 crore.
- Of every ₹100 that came in during FY26, ₹34.4 went on staff, ₹27.0 on agent commissions and ₹16.9 on advertising; ₹9.4 was left as profit.
03Who pays it
Who pays PB Fintech?
Insurers (insurance broking)
89.6%
of revenue
Commissions from insurers for policies sold in India and the UAE. FY26 segment revenue: ₹6,089.3 crore.
Lenders and other partners (other services)
10.4%
of revenue
Fees for loans and credit cards taken through Paisabazaar and PB Connect, plus marketing and consulting services. FY26 segment revenue: ₹704.7 crore.
- Insurers (insurance broking)89.6%
- Lenders and other partners (other services)10.4%
How spread out the customers are
One insurer paid ₹627.6 crore in FY26, 9.2% of revenue (Cityfort calculation: ₹627.6 crore ÷ ₹6,794.0 crore). Three customers in other services paid ₹354.1 crore. The company does not name them. Policybazaar had 29.7 million transacting consumers by 30 Sep 2026, by the company's count.
- Largest customer
- 9%
04How it makes money
How does PB Fintech make money?
Revenue grew faster than staff costs, and renewals keep paying, so profit per ₹100 of revenue turned positive.
Revenue grew from ₹1,425 crore in FY22 to ₹6,794 crore in FY26. Employee costs fell from ₹88.1 to ₹36.3 per ₹100 of revenue (Cityfort calculation), and ESOP costs from ₹607 crore to ₹194 crore. Renewal and trail revenue, earned when customers renew policies, was ₹935 crore in FY26, by the company's measure.
Profit per ₹100 of revenue (Cityfort calculation)
−₹58.5₹9.9
FY22 to FY26
- Customers compare and buy insurance on Policybazaar or through PB Partners agents.
- The insurer pays a commission; from the end of Q3 FY25, in instalments over the policy term, the company says.
- When customers renew, PB Fintech earns renewal and trail revenue: ₹935 crore in FY26 (company measure).
- Staff costs grew slower than revenue: ₹36.3 per ₹100 of revenue in FY26, from ₹88.1 in FY22.
- So profit per ₹100 of revenue went from a loss of ₹58.5 in FY22 to a profit of ₹9.9 in FY26.
↺ Step 5 feeds back into step 1.
05Business segments · FY26
Which businesses make up PB Fintech?
Insurance broking
89.6%Insurance sold through Policybazaar, PB Partners, PB for Business and Policybazaar.ae. Segment profit before interest and tax: ₹860.8 crore in FY26.
Revenue ₹6,089 cr · Operating profit ₹861 cr
Other services (incl. Paisabazaar)
10.4%Loan and card marketplaces (Paisabazaar, PB Connect), online marketing and consulting. Segment loss before interest and tax: ₹116.3 crore in FY26.
Revenue ₹705 cr · Operating profit −₹116 cr
How the mix changed
- Insurance broking
- Other services (incl. Paisabazaar)
Revenue by segment, Q4 FY25 to Q2 FY27.
₹ crore
See the numbers
Sources (8)
- Q4 FY25 and FY25 consolidated results (Integrated Filing XBRL)
- Q1 FY26 consolidated results (Integrated Filing XBRL)
- Q2 FY26 consolidated results (Integrated Filing XBRL)
- Q3 FY26 consolidated results (Integrated Filing XBRL)
- Q4 FY26 and FY26 consolidated results (Integrated Filing XBRL)
- Q1 FY27 consolidated results (Integrated Filing XBRL)
- Q2 FY27 consolidated results (Integrated Filing XBRL)
- Integrated Annual Report FY26 (2025-26), incl. consolidated financial statements and BRSR
06The numbers · Consolidated · ₹ crore
How has PB Fintech done?
Revenue
₹6,794 crFY26
Revenue grew every year, from ₹1,425 crore in FY22 to ₹6,794 crore in FY26, and was ₹2,178 crore in Q2 FY27, up 35.0% from Q2 FY26.
₹ crore
See the numbers
Net profit
₹670 crFY26
PB Fintech lost ₹833 crore in FY22 and ₹487 crore in FY23, then made ₹67 crore in FY24, ₹352 crore in FY25 (including a ₹41.1 crore exceptional gain) and ₹670 crore in FY26.
₹ crore
See the numbers
Net profit for every ₹100 of revenue
₹9.9FY26
EBITDA (Cityfort calculation: profit before tax + finance costs + depreciation − other income) was ₹7.5 per ₹100 of revenue in FY26, against −₹63.3 in FY22; FY25's ₹2.7 includes the ₹41.1 crore exceptional gain (₹1.9 without it, Cityfort calculation), and the company's own Adjusted EBITDA, which leaves out ESOP costs, was ₹725 crore in FY26.
Net margin: ₹ of net profit per ₹100 of revenue
See the numbers
Free cash flow
−₹38.4 crFY26
Free cash flow was negative every year from FY22 (−₹1,601 crore) to FY26 (−₹38 crore); trade receivables rose from ₹1,115 crore to ₹1,968 crore during FY26 after insurers began paying commissions in instalments over the policy term, the company says.
₹ crore · cash from operations minus spending on plants and equipment
See the numbers
See all yearly numbers
EBITDA = profit before interest, tax and wear-and-tear of assets. Financial year runs April to March (March year end). Net profit is the share belonging to the company's owners. Total net income differs from net profit to the company's owners: Total FY24 profit was ₹64.4 crore; the owners' share was ₹67.0 crore after minority holders' share of subsidiaries' losses.
Sources (15)
- Q4 FY22 and FY22 consolidated results (XBRL)
- Annual Report FY22 (2021-22), incl. consolidated financial statements
- Q4 FY23 and FY23 consolidated results (XBRL)
- Annual Report FY23 (2022-23), incl. consolidated financial statements (zip on NSE)
- Q4 FY24 and FY24 consolidated results (XBRL)
- Annual Report FY25 (2024-25), incl. consolidated financial statements
- Integrated Annual Report FY26 (2025-26), incl. consolidated financial statements and BRSR
- Q4 FY25 and FY25 consolidated results (Integrated Filing XBRL)
- Q4 FY26 and FY26 consolidated results (Integrated Filing XBRL)
- Q3 FY25 consolidated results (XBRL)
- Q1 FY26 consolidated results (Integrated Filing XBRL)
- Q2 FY26 consolidated results (Integrated Filing XBRL)
- Q3 FY26 consolidated results (Integrated Filing XBRL)
- Q1 FY27 consolidated results (Integrated Filing XBRL)
- Q2 FY27 consolidated results (Integrated Filing XBRL)
07Who runs it
Who runs PB Fintech, and did they deliver?
Yashish Dahiya
Chairman, Executive Director & CEO
Re-appointed for 5 Jul 2026 to 4 Jul 2031. Held 3.30% of the shares on 30 Sep 2026, filed as a public shareholder.
Alok Bansal
Executive Vice Chairman & Whole-time Director
Re-appointed for 28 Jun 2026 to 27 Jun 2031.
Sarbvir Singh
Joint Group CEO & Whole-time Director
Mandeep Mehta
Chief Financial Officer
Sajja Praveen Chowdary
CEO & Principal Officer, Policybazaar · since 2026
From 7 Apr 2026, with IRDAI approval, succeeding Tarun Mathur.
Santosh Agarwal
CEO, Paisabazaar
What they said, and what happened
3 too early to tell
Said on 5 Aug 2026
Management said on the 5 Aug 2026 call that by March 2027 PB Health would reach an annual run rate of about ₹500 crore and break even, calling it an internal target it might or might not achieve.
Too early to tellWhat happened
On 30 Oct 2026 Alok Bansal said that around March the run rate should be ₹40–45 crore a month, about ₹500 crore a year. PB Fintech's share of associates' results was a loss of ₹4.49 crore in Q2 FY27.
Said on 30 Oct 2026
Yashish Dahiya said on the 30 Oct 2026 call that Q2 FY27 premium of ₹9,385 crore set PB Fintech up for more than ₹40,000 crore of insurance premium in FY27.
Too early to tellWhat happened
H1 FY27 premium was ₹17,757 crore (₹8,372 crore + ₹9,385 crore, Cityfort calculation; company measure without GST). FY27 ends on 31 Mar 2027.
Said on 5 Sep 2026
The FY26 annual report says that, with insurers' move to paying commission in instalments now a full year old, management expects receivable days to stabilise.
Too early to tellWhat happened
Receivable days were 82 in FY25 and 106 in FY26. Trade receivables rose from ₹1,967.7 crore on 31 Mar 2026 to ₹2,409.3 crore on 30 Sep 2026; the half-year results do not give receivable days.
Sources (9)
- Integrated Annual Report FY26 (2025-26), incl. consolidated financial statements and BRSR
- Reg 30: re-appointment of Yashish Dahiya and Alok Bansal for five years from 2026
- Shareholding pattern as of 30 Sep 2026 (XBRL)
- Reg 30: change of Policybazaar CEO and Principal Officer (7 Apr 2026)
- Q2 FY27 earnings call transcript (call 30 Oct 2026)
- Q1 FY27 earnings call transcript (call 5 Aug 2026)
- Q2 FY27 consolidated results (Integrated Filing XBRL)
- Q1 FY27 board outcome: results, press release and shareholder presentation
- Q2 FY27 board outcome: results, press release and shareholder presentation
08What could go wrong
What could go wrong for PB Fintech?
- Regulation
Draft IRDAI rules on commissions
Insurance broking was 89.6% of FY26 revenue. IRDAI's Sep 2026 consultation paper, "Recalibrating Economics of Insurance Distribution", proposes changes to distribution expense structures and commission limits; the company told the exchanges on 27 Sep 2026 it is a draft, not a final order. On 24 Sep 2026 management estimated that, under the draft as proposed, general insurance revenue in net-present-value terms would be one-third to 40% of the level at that time, and that life insurance would see no major impact.
Watch IRDAI's final framework and its start date, and insurance revenue in the quarters after it.
- Cash and liquidity
Profit has not turned into free cash flow
Insurers moved to paying commission in instalments over the policy term from the end of Q3 FY25, the company says. Trade receivables rose from ₹1,115.1 crore on 31 Mar 2025 to ₹1,967.7 crore on 31 Mar 2026, and receivable days from 82 to 106. Free cash flow was negative in every year from FY22 to FY26.
Watch Trade receivables and operating cash flow in the half-year results (H1 FY27 operating cash flow: ₹62.3 crore).
- Demand
Loan and card business depends on lenders
Core Online credit revenue fell 11% to ₹445 crore in FY26 and core disbursal 20% to ₹9,474 crore, which the annual report says reflected tighter lender supply in unsecured credit. Core disbursal was ₹2,791 crore in Q2 FY27, up 22%.
Watch Core disbursal and core credit revenue each quarter (Q2 FY27 core credit revenue: ₹125 crore).
- Concentration
Large single customers
One insurer paid ₹627.6 crore in FY26, about 9.2% of revenue (Cityfort calculation), and three customers in other services ₹354.1 crore. The company does not name them.
Watch The customer note in the FY27 annual report.
- Legal
Benami and tax cases at Paisabazaar
A Benami Act authority confirmed on 24 Mar 2026 an order alleging Paisabazaar was the beneficial owner in its transactions with certain vendors; the company said it would appeal. Income-tax disallowances of ₹85.60 crore and ₹60.31 crore relating to vendors were confirmed on 30 Apr 2026 and appealed to the ITAT on 26 Jun 2026.
Watch The ITAT hearing, adjourned to 25 Nov 2026, and the Benami appeal.
- Demand
Advertising cost to win customers
Advertising and promotion cost ₹1,212.6 crore in FY26, ₹16.9 of every ₹100 that came in, and ₹446.7 crore in Q2 FY27. On the 30 Oct 2026 call management said demand had been tough that quarter and it had spent more on marketing to get leads.
Watch Advertising and promotion cost against revenue each quarter.
- Execution
Losses at PB Health, a hospital associate
PB Fintech invested ₹539.4 crore in PB Health, a hospital company, which became an associate on 24 Apr 2025; the board had approved up to ₹696 crore. PB Fintech's share of associates' results, mainly PB Health, was a loss of ₹6.02 crore in Q4 FY26 and ₹4.49 crore in Q2 FY27.
Watch Share of associates' results each quarter, and PB Health's run rate against management's target, from the 5 Aug 2026 call, of about ₹500 crore a year by Mar 2027.
Sources (12)
- Clarification on price movement: IRDAI consultation paper on the economics of insurance distribution
- Transcript of analyst and investor call on the IRDAI consultation paper (call 24 Sep 2026)
- Q4 FY26 and FY26 consolidated results (Integrated Filing XBRL)
- Integrated Annual Report FY26 (2025-26), incl. consolidated financial statements and BRSR
- Q2 FY27 consolidated results (Integrated Filing XBRL)
- Q2 FY27 board outcome: results, press release and shareholder presentation
- Reg 30: Benami Act adjudicating authority order on Paisabazaar (24 Mar 2026)
- Reg 30: CIT(A) order confirming income-tax disallowances at Paisabazaar (30 Apr 2026)
- Q2 FY27 earnings call transcript (call 30 Oct 2026)
- Reg 30: Rs 539.4 crore invested in PB Healthcare Services (24 Apr 2025)
- Reg 30: approval to invest up to Rs 696 crore in PB Healthcare Services (11 Mar 2025)
- Q1 FY27 earnings call transcript (call 5 Aug 2026)
09Supporters and critics
What do supporters and critics point to?
What supporters point to
- Revenue grew from ₹1,425 crore in FY22 to ₹6,794 crore in FY26, and a ₹833 crore loss in FY22 became a ₹670 crore profit in FY26.
- Core renewal and trail revenue was ₹1,097 crore in the 12 months to Sep 2026, up 42%, by the company's measure.
- PB Fintech has no borrowings, and the company puts its net cash and investments at ₹5,109 crore on 31 Mar 2026.
- Yashish Dahiya said on 30 Oct 2026 that more than a quarter of India's pure term premium and 17.8% of retail health premium came through PB Fintech last year.
What critics point to
- Management estimated on 24 Sep 2026 that, under IRDAI's draft as proposed, its general insurance revenue in net-present-value terms would be one-third to 40% of the level at that time.
- Free cash flow was negative every year from FY22 to FY26, and trade receivables rose from ₹1,115 crore to ₹1,968 crore during FY26.
- Core credit revenue fell 11% in FY26 to ₹445 crore and core disbursal 20%, and other services lost ₹116.3 crore before interest and tax.
- Paisabazaar faces a Benami Act order alleging it was the beneficial owner in transactions with certain vendors, and confirmed tax disallowances of ₹85.60 crore and ₹60.31 crore, both under appeal or to be appealed.
10What to watch next
What should you watch next at PB Fintech?
Next event
Q3 FY27 results
Date not announced yet.
IRDAI's final commission rules
The Sep 2026 paper is a draft. Management said on 24 Sep 2026 that the timeline and whether it applies to past policies were not yet clear.
Receivables and cash
Trade receivables were ₹2,409.3 crore on 30 Sep 2026. Operating cash flow was ₹62.3 crore in H1 FY27, against −₹110.8 crore in H1 FY26.
Loans after PB Connect's wholesale exit
Total disbursal was ₹4,739 crore in Q2 FY27, against ₹8,570 crore a year earlier, while core disbursal rose to ₹2,791 crore from ₹2,280 crore (company measures).
11Key facts
Key facts about PB Fintech
- What does PB Fintech do?
- PB Fintech Ltd, incorporated in 2008 and based in Gurugram, runs Policybazaar, an online insurance marketplace and broker, and Paisabazaar, an online marketplace for loans and credit cards. Insurance premium of ₹29,934 crore (without GST, the company's own measure) was placed through PB Fintech's platforms in FY26.
- How does PB Fintech make money?
- PB Fintech earns commissions and fees from insurers and lenders for the customers it brings them. In FY26 insurance broking brought in ₹6,089.3 crore, 89.6% of PB Fintech's ₹6,794.0 crore revenue, and other services such as loan and card marketplaces ₹704.7 crore, 10.4%.
- Who are PB Fintech's customers?
- PB Fintech is paid by insurers and lenders: Policybazaar worked with 53 insurers and Paisabazaar with more than 70 lenders in FY26. One insurer paid PB Fintech ₹627.6 crore in FY26, about 9.2% of revenue (Cityfort calculation); the company does not name it.
- How big is PB Fintech?
- PB Fintech's FY26 revenue was ₹6,794.0 crore and its profit to shareholders ₹669.9 crore, up from ₹4,977.2 crore and ₹352.1 crore in FY25. In Q2 FY27 (Jul–Sep 2026) PB Fintech's revenue was ₹2,177.7 crore and profit to shareholders ₹192.5 crore.
- Who owns PB Fintech?
- PB Fintech has no promoter. On 30 Sep 2026 Indian institutions held 44.86% of PB Fintech, foreign investors 27.12%, other shareholders 27.89% and an employee share trust 0.14%. The largest named holders were HDFC Mutual Fund's Flexi Cap scheme (6.68%) and Info Edge (India) (6.47%).
- Does PB Fintech have debt?
- PB Fintech had no borrowings on 30 Sep 2026; its only debt-like item is lease liabilities on offices, ₹360.2 crore on 31 Mar 2026. PB Fintech's FY26 annual report says it has no credit rating because it has no debt.
- What is PB Partners?
- PB Partners is PB Fintech's platform for insurance agents. It had more than 5.7 lakh advisors and 1.31 lakh active partners in Q2 FY27, when ₹1,989 crore of premium (without GST, company measure) was placed through PB Partners.
- How much do employee stock options cost PB Fintech?
- PB Fintech's share-based payment (ESOP) expense was ₹607.2 crore in FY22, 42.6% of revenue, and ₹194.2 crore in FY26, 2.9% of revenue (Cityfort calculation). It is a non-cash cost counted in employee costs.
- When did PB Fintech list on the stock exchanges?
- PB Fintech's shares started trading on NSE and BSE on 15 Nov 2021. Its IPO sold 58,262,397 shares for ₹5,709.7 crore: ₹3,750 crore of new shares for the company and ₹1,959.7 crore sold by existing shareholders.
Sources (9)
- Integrated Annual Report FY26 (2025-26), incl. consolidated financial statements and BRSR
- Q4 FY26 board outcome: results, press release and shareholder presentation
- Q4 FY26 and FY26 consolidated results (Integrated Filing XBRL)
- Q2 FY27 consolidated results (Integrated Filing XBRL)
- Shareholding pattern as of 30 Sep 2026 (XBRL)
- Red Herring Prospectus (25 Oct 2021), IPO of PB Fintech Limited
- Q2 FY27 board outcome: results, press release and shareholder presentation
- Q4 FY22 and FY22 consolidated results (XBRL)
- Basis of allotment and listing advertisement (IPO at Rs 980; trading from 15 Nov 2021)
Terms on this page
- Capital expenditure (capex)
- Customer concentration
- EBITDA
- FII and DII holding
- Free cash flow
- Market capitalisation
- Net debt
- Net profit
- Operating margin
- Promoter holding
Each explains the term in plain English, with the same number from other companies on Cityfort.
Go deeper
More detail from the same filings. Open any section.
12What it sells
12What it sells
What does PB Fintech sell?
Policybazaar (insurance)
Term life, health, savings, motor and travel insurance from 53 insurers, sold by an IRDAI-licensed broker subsidiary, Policybazaar Insurance Brokers. Health and term cover was more than 70% of Core Online insurance revenue in FY26.
Paisabazaar (loans and cards)
Personal loans, credit cards and secured loans from more than 70 lending partners, plus free credit scores. 63.4 million people had used its credit-score service by 30 Sep 2026, by the company's count.
PB Partners (insurance agents)
A platform through which agents sell insurance. 1.31 lakh partners were active in Q2 FY27; 76% of its premium came from Tier 2 and Tier 3 cities.
Other new initiatives
PB for Business (insurance for companies), Policybazaar.ae in the UAE, PB Connect (a platform for home-loan agents), Pensionbazaar and PB Pay, which got an RBI payment-aggregator authorisation on 6 Feb 2026.
Think of it like this
Like a showroom that stocks many brands of insurance and loans, where the brand pays the showroom for each sale.
What it does
- Does: Lets people compare and buy insurance policies and apply for loans and credit cards
- Does: Earns commissions from insurers and fees from lenders
- Does: Runs a platform through which agents sell insurance (PB Partners)
What it does not do
- Does not: Does not take insurance risk or pay claims: the insurers do
- Does not: Does not lend from its own balance sheet: partner lenders do
- Does not: Does not show PB Health's hospital revenue: PB Health has been an associate, not a subsidiary, since 24 Apr 2025
13How the money flows
13How the money flows · FY26
How does money flow through PB Fintech?
Money in
- Revenue from operations (commissions and fees)₹6,794 cr
- Other income₹372 cr
The company
PB Fintech
₹7,166 cr came in
Money out
- Employees (incl. ₹194.2 crore of ESOP costs)₹2,466 cr
- Commissions to PB Partners and PB Connect agents₹1,934 cr
- Advertising and promotion₹1,213 cr
- Internet, other running costs and share of associates' loss₹673 cr
- Depreciation and interest on office leases₹173 cr
- Income tax₹37.2 cr
- Net profit (incl. ₹0.2 crore for minority holders)₹670 cr
- In FY26 insurers, lenders and other partners paid PB Fintech ₹6,794 crore of commissions and fees.
- Other income added ₹372 crore, down from ₹408 crore in FY25.
- Staff cost ₹2,466 crore, including ₹194 crore of employee stock option (ESOP) costs, which are paid in shares, not cash.
- Payouts to PB Partners and PB Connect agents took ₹1,934 crore and advertising ₹1,213 crore.
- After other costs, depreciation, lease interest and ₹37 crore of tax, ₹670 crore was left as profit.
14What it needs to run
14What it needs to run
What does PB Fintech need to run?
Insurance broking licence
Policybazaar Insurance Brokers holds an IRDAI broking licence. IRDAI, the insurance regulator, also sets rules on what insurers may pay distributors.
Insurer and lender partners
53 insurers and more than 70 lenders offered their products on its platforms in FY26.
People
4,798 employees and 23,532 workers on 31 Mar 2026; under the new Labour Codes part of the staff is now classed as workers, so totals differ from FY25. Employee costs were ₹2,466 crore in FY26.
Advertising
₹1,212.6 crore went on advertising and promotion in FY26, against ₹1,090.1 crore in FY25.
Agent network
More than 5.7 lakh advisors were registered on PB Partners in Q2 FY27, by the company's count.
15Where it sells
15Where it sells · FY26
Where does PB Fintech sell?
- India96%
- UAE (Policybazaar.ae)4%
16Where growth could come from
16Where growth could come from
Where could PB Fintech's growth come from?
On the 30 Oct 2026 call, Chairman and Group CEO Yashish Dahiya said Q2 FY27 premium of ₹9,385 crore set PB Fintech up for more than ₹40,000 crore of insurance premium in FY27. He also said, of the IRDAI draft: "Lower distribution payouts will reduce our insurance distribution revenue, for sure."
Health and term insurance
WorkingNew health and term premium +42%, Q2 FY27
Core Online new health and term premium grew 42% year on year in Q2 FY27, and new health premium 46%, the company reported.
Status: Working, on track against what the company said.
Renewal and trail revenue
Working₹1,097 crore, 12 months to Sep 2026
Up 42% from ₹774 crore a year earlier, by the company's measure. It rose from ₹668 crore in FY25 to ₹935 crore in FY26.
Status: Working, on track against what the company said.
PB Partners
Working₹1,989 crore premium, Q2 FY27, +36%
Premium without GST, company measure. PB Partners revenue was ₹698 crore in Q2 FY27, up 39%, and active partners rose 55% to 1.31 lakh.
Status: Working, on track against what the company said.
Paisabazaar loans and cards
MixedCore disbursal ₹2,791 crore, Q2 FY27, +22%
In FY26 core disbursal fell 20% to ₹9,474 crore and core credit revenue 11% to ₹445 crore, which the annual report says reflected tighter lender supply in unsecured credit. Core credit revenue rose 19% in Q2 FY27.
Status: Mixed, partly on track.
UAE (Policybazaar.ae)
Working₹271.2 crore revenue, FY26
UAE revenue was ₹251.1 crore in FY25. Yashish Dahiya said on 30 Oct 2026 that UAE premium grew 36% in Q2 FY27.
Status: Working, on track against what the company said.
PB Health (hospitals)
Early₹539.4 crore invested, Apr 2025
PB Health is an associate, so only PB Fintech's share of its result shows in profit. Alok Bansal said on 30 Oct 2026 that around March the run rate should be ₹40–45 crore a month, about ₹500 crore a year.
Status: Early, too early to judge.
PB Pay (payments)
NewRBI authorisation, 6 Feb 2026
RBI authorised PB Pay as a payment aggregator on 6 Feb 2026.
Status: New, recently announced.
Status compares progress with what the company itself said it would do: Working = on track against what the company said; Mixed = partly on track; Behind = behind the company's own plan; New = recently announced; Early = too early to judge.
Sources (6)
- Q2 FY27 earnings call transcript (call 30 Oct 2026)
- Q2 FY27 board outcome: results, press release and shareholder presentation
- Q4 FY26 board outcome: results, press release and shareholder presentation
- Integrated Annual Report FY26 (2025-26), incl. consolidated financial statements and BRSR
- Reg 30: Rs 539.4 crore invested in PB Healthcare Services (24 Apr 2025)
- Reg 30: RBI payment aggregator authorisation to PB Pay (6 Feb 2026)
17Financial strength and debt
17Financial strength · 30 Sep 2026
How much debt does PB Fintech have?
- Total debt₹0 cr
- Cash and investments₹3,254 cr
- Net cash (cash minus debt)₹3,254 cr
- Net worth (shareholders' money)₹7,775 cr
- Debt to equity
- 0×
- ₹ of debt for every ₹1 of shareholders' money
- Cash and investments = cash ₹389.8 crore + other bank balances ₹62.0 crore + current investments ₹1,715.4 crore + non-current investments ₹1,086.5 crore (Cityfort calculation from the Q2 FY27 results). It leaves out deposits held in other financial assets.
- The company's own measure, net cash and investments including those deposits, was ₹5,109 crore on 31 Mar 2026.
- The only finance cost is interest on leased offices and call and service centres; lease liabilities were ₹360.2 crore on 31 Mar 2026.
- Trade receivables were ₹2,409.3 crore on 30 Sep 2026 (₹2,115.9 crore current + ₹293.4 crore non-current), against ₹1,967.7 crore on 31 Mar 2026 (Cityfort sums).
- Investment in associates, mainly PB Health, was ₹553.2 crore on 31 Mar 2026.
18Who owns it
18Who owns it · Q2 FY27
Who owns PB Fintech?
- Foreign institutions (FII)27.1%
- Indian institutions (DII)44.9%
- Public27.9%
- Employee share (ESOP) trust0.1%
No promoter
PB Fintech reports no promoter group in Q2 FY27: no founder family or parent company is filed as controlling it, so there are no promoter shares to pledge.
How ownership changed
* Others = Employee share (ESOP) trust.
Sources (12)
- Shareholding pattern as of 30 Sep 2026 (XBRL)
- Shareholding pattern as of 30 Jun 2026 (XBRL)
- Shareholding pattern as of 31 Mar 2026 (XBRL)
- Shareholding pattern as of 31 Dec 2025 (XBRL)
- Shareholding pattern as of 30 Sep 2025 (XBRL)
- Shareholding pattern as of 30 Jun 2025 (XBRL)
- Shareholding pattern as of 31 Mar 2025 (XBRL)
- Shareholding pattern as of 31 Dec 2024 (XBRL)
- Shareholding pattern as of 30 Sep 2024 (XBRL)
- Shareholding pattern as of 30 Jun 2024 (XBRL)
- Shareholding pattern as of 31 Mar 2024 (XBRL)
- Shareholding pattern as of 31 Dec 2023 (XBRL)
19What it does with profit
19What it does with profit
What does PB Fintech do with its profit?
Money raised · 15 Nov 2021
IPO of 58,262,397 shares at ₹980 each (₹5,709.7 crore): a fresh issue of ₹3,750 crore, money for the company, and an offer for sale of ₹1,959.7 crore by existing shareholders. Shares started trading on 15 Nov 2021.
₹3,750 cr
20Governance signals
20Governance signals
What do PB Fintech's governance filings show?
- Auditor
- Walker Chandiok & Co LLP, since 2023
- Auditor changes
- 23 Sep 2023: Price Waterhouse Chartered Accountants LLP → Walker Chandiok & Co LLP (Price Waterhouse retired at the end of its term; Walker Chandiok was appointed from the AGM of 23 Sep 2023 and audits FY24 onward.)
- Audit qualifications
- None reported
- Related-party dealings
- PB Health (PB Healthcare Services), a hospital company, became an associate on 24 Apr 2025 after PB Fintech invested ₹539.4 crore in a round of up to ₹1,461.6 crore with outside investors. Shareholders approved, by postal ballot on 13 Apr 2025, material related-party transactions with PB Health and let Yashish Dahiya, Alok Bansal and other key managers deal with it; about 82.6% of votes were in favour and 17.4% against.
- Credit rating
- No public credit rating found
Flags to know about
other · 30 Sep 2026
No promoter
PB Fintech's IPO document says it is professionally managed and has no identifiable promoter. On 30 Sep 2026 the largest named holders were HDFC Mutual Fund's Flexi Cap scheme (6.68%), Info Edge (India) (6.47%) and ICICI Prudential's Large & Mid Cap scheme (4.31%); Yashish Dahiya held 3.30%.
other · 30 Sep 2026
How Cityfort groups the shareholders
Foreign investors = foreign portfolio investors and other foreign institutions. Macritchie Investments was filed under foreign direct investment, within foreign institutions, in Jun 2026 and under foreign companies, within other shareholders, in Sep 2026 (4.01%). So part of the fall in foreign investors' share, from 37.30% to 27.12%, is a change of category.
other · 29 Aug 2025
Makesense merger changed the holder list
Makesense Technologies, an Info Edge group company holding 59.89 million PB Fintech shares (12.94%), merged into PB Fintech under an NCLT order of 29 Aug 2025. PB Fintech issued shares to Makesense's shareholders in the same proportion, so Info Edge and Macritchie Investments each held 6.47% from Mar 2026. FY25 profit was restated down by ₹0.94 crore.
disclosure · 2 Feb 2026
Insurance premium is now shown without GST
From the Q3 FY26 presentation (2 Feb 2026), the company reports insurance premium without GST and restated earlier periods. Older presentations included GST: Q2 FY26 premium was ₹7,605 crore with GST and ₹6,824 crore without. This page uses only the series without GST.
disclosure
Key business numbers are company-defined
Insurance premium, loan disbursal, renewal revenue, the Core Online / New Initiatives revenue split, contribution and Adjusted EBITDA are the company's own measures, not accounting standards. Adjusted EBITDA leaves out ESOP costs (share-based payments and employee performance units).
disclosure · 31 Mar 2026
No credit rating
The FY26 annual report says PB Fintech did not have any debt, so no credit rating was obtained.
regulatory · 4 Aug 2025
IRDAI penalty of ₹5 crore on Policybazaar (Aug 2025)
After a June 2020 inspection, IRDAI's order of 4 Aug 2025 levied a ₹5 crore penalty on Policybazaar for violations of IRDAI regulations on directorships held by key managers and the principal officer, product display, outsourcing agreements, tagging of policies and premium remittance, with further directions. The penalty was paid on 17 Sep 2025.
regulatory · 13 Aug 2026
IRDAI letter of advice and show cause notice (Aug 2026)
On 13 Aug 2026 IRDAI issued a letter of advice on certain documentary and process matters from its Oct 2024 inspection of Policybazaar, and a show cause notice on some observations. The company said there is no material impact in monetary terms.
regulatory · 4 Mar 2025
SEBI settlement by the Chairman and CEO (Mar 2025)
SEBI's settlement order of 4 Mar 2025 disposed of proceedings against Yashish Dahiya, as Chairman and CEO, alleging that a USD 2 million investment by a PB Fintech subsidiary for 26.72% of YKNP Marketing Management, UAE, was not identified as unpublished price-sensitive information. He settled without admitting or denying the facts and conclusions of law and paid ₹942,500, the order says.
regulatory · 24 Mar 2026
Benami Act order on Paisabazaar (Mar 2026)
On 24 Mar 2026 the Benami Act adjudicating authority confirmed an order of 27 Feb 2025 on certain vendors of Paisabazaar, in which Paisabazaar was alleged to be the beneficial owner in its transactions with them. The company said the order is appealable, Paisabazaar would appeal, and there was no financial impact at that point.
regulatory · 26 Jun 2026
Income-tax and GST matters at Paisabazaar
On 30 Apr 2026 the CIT(A) confirmed disallowances of ₹85.60 crore (FY 2022-23) and ₹60.31 crore (FY 2021-22) relating to certain vendors, and directed the tax officer to verify a loss set-off claim; Paisabazaar appealed to the ITAT on 26 Jun 2026. The auditor's report carries an emphasis of matter on it, not a qualification. Separately, ₹14.50 crore was paid under protest after a 2022 GST search, and fully provided for in Q1 FY25.
other · 17 Sep 2026
Two market reports denied in 2026
On 6 Feb 2026 the company denied news of a USD 1 billion fundraise. On 17 Sep 2026 it denied market speculation that Yashish Dahiya would step down.
Sources (19)
- Integrated Annual Report FY26 (2025-26), incl. consolidated financial statements and BRSR
- Annual Report FY23 (2022-23), incl. consolidated financial statements (zip on NSE)
- Reg 30: Rs 539.4 crore invested in PB Healthcare Services (24 Apr 2025)
- Red Herring Prospectus (25 Oct 2021), IPO of PB Fintech Limited
- Shareholding pattern as of 30 Sep 2026 (XBRL)
- Shareholding pattern as of 30 Jun 2026 (XBRL)
- Shareholding pattern as of 31 Dec 2025 (XBRL)
- Shareholding pattern as of 31 Mar 2026 (XBRL)
- Q3 FY26 board outcome: results, press release and shareholder presentation
- Q2 FY26 board outcome: results, press release and shareholder presentation
- Q4 FY26 board outcome: results, press release and shareholder presentation
- Q2 FY27 board outcome: results, press release and shareholder presentation
- Reg 30: IRDAI order dated 4 Aug 2025 levying a Rs 5 crore penalty on Policybazaar
- Reg 30: IRDAI letter of advice and show cause notice (inspection Oct 2024), received 13 Aug 2026
- Reg 30: SEBI settlement order (4 Mar 2025) in respect of the Chairman and CEO
- Reg 30: Benami Act adjudicating authority order on Paisabazaar (24 Mar 2026)
- Reg 30: CIT(A) order confirming income-tax disallowances at Paisabazaar (30 Apr 2026)
- Clarification on news about a USD 1 billion fundraise (6 Feb 2026)
- Clarification on market rumour about the Chairman and CEO (17 Sep 2026)
21What the market paid
21What the market paid · price as of 11 Nov 2026
What did the market pay for PB Fintech on 11 Nov 2026?
Price as of 11 Nov 2026 (shown for education; prices change daily).
PB Fintech's shares closed at ₹976.00 on NSE on 11 Nov 2026 (price as of 11 Nov 2026). Market value = that price × 462,752,755 shares (30 Sep 2026 shareholding pattern) = ₹45,165 crore. P/E = market value ÷ profit to shareholders of the last four quarters (Q3 FY26–Q2 FY27, ₹805.8 crore) = 56.0 as of 11 Nov 2026; it shows how many rupees buyers paid for each rupee of yearly profit on that date. P/B = market value ÷ net worth on 30 Sep 2026 (₹7,774.8 crore) = 5.8. All are Cityfort calculations.
- Share price
- ₹976.00
- Market value (market cap)
- ₹45,165 cr
- P/E
- 56×
- P/B
- 5.8×
Source: NSE historical price data (security-wise), POLICYBZR EQ, 1-11 Nov 2026; Shareholding pattern as of 30 Sep 2026 (XBRL); Q3 FY26 consolidated results (Integrated Filing XBRL) and 3 more
Sources (6)
- NSE historical price data (security-wise), POLICYBZR EQ, 1-11 Nov 2026
- Shareholding pattern as of 30 Sep 2026 (XBRL)
- Q3 FY26 consolidated results (Integrated Filing XBRL)
- Q4 FY26 and FY26 consolidated results (Integrated Filing XBRL)
- Q1 FY27 consolidated results (Integrated Filing XBRL)
- Q2 FY27 consolidated results (Integrated Filing XBRL)
22How it got here
22How it got here
How did PB Fintech get here?
2008
Milestone
Incorporated
Incorporated on 4 Jun 2008 as Etechaces Marketing and Consulting Pvt Ltd; Policybazaar was founded the same year.
2020
Milestone
Renamed PB Fintech
Became PB Fintech Pvt Ltd on 18 Sep 2020, and a public company, PB Fintech Ltd, in 2021.
2021
Milestone
IPO and listing
The red herring prospectus was filed on 25 Oct 2021. The IPO raised ₹5,709.7 crore, ₹3,750 crore of it new money, and shares started trading on 15 Nov 2021.
2024
Business-model change
First yearly profit (FY24)
Profit to shareholders was ₹67.0 crore in FY24, after losses of ₹832.9 crore in FY22 and ₹487.2 crore in FY23.
2024
Business-model change
Insurers start paying in instalments
From the end of Q3 FY25 insurers moved to paying commission in instalments over the policy term, the company says, and receivables grew.
2025
Milestone
PB Health becomes an associate
PB Fintech invested ₹539.4 crore in PB Health, a hospital company, which became an associate on 24 Apr 2025.
2025
Milestone
Makesense merger
NCLT approved the merger of Makesense Technologies, an Info Edge group holder of 12.94%, into PB Fintech on 29 Aug 2025.
2026
Business-model change
PB Connect stops wholesale home loans
Management said on 6 May 2026 it had stopped PB Connect's wholesale business with larger agents in January, and that this had no impact on overall profits. Total disbursal fell year on year from Q4 FY26.
2026
Milestone
IPO money fully used
On 31 Mar 2026 the last IPO money for overseas expansion paid for Genesis Group, owner of Policybazaar's UAE broker.
2026
Milestone
IRDAI draft on distribution costs
IRDAI published a consultation paper proposing new commission and distribution expense limits in Sep 2026; PB Fintech held an analyst call on 24 Sep 2026.
Sources (13)
- Integrated Annual Report FY26 (2025-26), incl. consolidated financial statements and BRSR
- Red Herring Prospectus (25 Oct 2021), IPO of PB Fintech Limited
- Basis of allotment and listing advertisement (IPO at Rs 980; trading from 15 Nov 2021)
- Q4 FY24 and FY24 consolidated results (XBRL)
- Q4 FY23 and FY23 consolidated results (XBRL)
- Annual Report FY22 (2021-22), incl. consolidated financial statements
- Reg 30: Rs 539.4 crore invested in PB Healthcare Services (24 Apr 2025)
- Shareholding pattern as of 31 Dec 2025 (XBRL)
- Q4 FY26 earnings call transcript (call 6 May 2026)
- Q4 FY26 board outcome: results, press release and shareholder presentation
- Reg 30: IPO proceeds earmarked for overseas expansion utilised (31 Mar 2026)
- Clarification on price movement: IRDAI consultation paper on the economics of insurance distribution
- Transcript of analyst and investor call on the IRDAI consultation paper (call 24 Sep 2026)
23Sources and changes
Where every number on this page comes from
Sources (53 documents)
- S1Integrated Annual Report FY26 (2025-26), incl. consolidated financial statements and BRSR · NSE (company filing, nsearchives.nseindia.com) · Tier 1: company or exchange filing · 5 Sep 2026
- S2Annual Report FY25 (2024-25), incl. consolidated financial statements · NSE (company filing, nsearchives.nseindia.com) · Tier 1: company or exchange filing · 4 Sep 2025
- S4Annual Report FY23 (2022-23), incl. consolidated financial statements (zip on NSE) · NSE (company filing, nsearchives.nseindia.com) · Tier 1: company or exchange filing · 1 Sep 2023
- S5Annual Report FY22 (2021-22), incl. consolidated financial statements · NSE (company filing, nsearchives.nseindia.com) · Tier 1: company or exchange filing · 3 Sep 2022
- S6Q2 FY27 consolidated results (Integrated Filing XBRL) · NSE (company filing, nsearchives.nseindia.com) · Tier 1: company or exchange filing · 30 Oct 2026
- S7Q1 FY27 consolidated results (Integrated Filing XBRL) · NSE (company filing, nsearchives.nseindia.com) · Tier 1: company or exchange filing · 5 Aug 2026
- S8Q4 FY26 and FY26 consolidated results (Integrated Filing XBRL) · NSE (company filing, nsearchives.nseindia.com) · Tier 1: company or exchange filing · 6 May 2026
- S9Q3 FY26 consolidated results (Integrated Filing XBRL) · NSE (company filing, nsearchives.nseindia.com) · Tier 1: company or exchange filing · 2 Feb 2026
- S10Q2 FY26 consolidated results (Integrated Filing XBRL) · NSE (company filing, nsearchives.nseindia.com) · Tier 1: company or exchange filing · 29 Oct 2025
- S11Q1 FY26 consolidated results (Integrated Filing XBRL) · NSE (company filing, nsearchives.nseindia.com) · Tier 1: company or exchange filing · 31 Jul 2025
- S12Q4 FY25 and FY25 consolidated results (Integrated Filing XBRL) · NSE (company filing, nsearchives.nseindia.com) · Tier 1: company or exchange filing · 15 May 2025
- S13Q3 FY25 consolidated results (XBRL) · NSE (company filing, nsearchives.nseindia.com) · Tier 1: company or exchange filing · 30 Jan 2025
- S16Q4 FY24 and FY24 consolidated results (XBRL) · NSE (company filing, nsearchives.nseindia.com) · Tier 1: company or exchange filing · 8 May 2024
- S17Q4 FY23 and FY23 consolidated results (XBRL) · NSE (company filing, nsearchives.nseindia.com) · Tier 1: company or exchange filing · 23 May 2023
- S18Q4 FY22 and FY22 consolidated results (XBRL) · NSE (company filing, nsearchives.nseindia.com) · Tier 1: company or exchange filing · 28 May 2022
- S19Q2 FY27 board outcome: results, press release and shareholder presentation · NSE (company filing, nsearchives.nseindia.com) · Tier 1: company or exchange filing · 30 Oct 2026
- S20Q1 FY27 board outcome: results, press release and shareholder presentation · NSE (company filing, nsearchives.nseindia.com) · Tier 1: company or exchange filing · 5 Aug 2026
- S21Q4 FY26 board outcome: results, press release and shareholder presentation · NSE (company filing, nsearchives.nseindia.com) · Tier 1: company or exchange filing · 6 May 2026
- S22Q3 FY26 board outcome: results, press release and shareholder presentation · NSE (company filing, nsearchives.nseindia.com) · Tier 1: company or exchange filing · 2 Feb 2026
- S23Q2 FY26 board outcome: results, press release and shareholder presentation · NSE (company filing, nsearchives.nseindia.com) · Tier 1: company or exchange filing · 29 Oct 2025
- S25Q2 FY27 earnings call transcript (call 30 Oct 2026) · NSE (company filing, nsearchives.nseindia.com) · Tier 1: company or exchange filing · 4 Nov 2026
- S26Q1 FY27 earnings call transcript (call 5 Aug 2026) · NSE (company filing, nsearchives.nseindia.com) · Tier 1: company or exchange filing · 11 Aug 2026
- S27Q4 FY26 earnings call transcript (call 6 May 2026) · NSE (company filing, nsearchives.nseindia.com) · Tier 1: company or exchange filing · 12 May 2026
- S29Transcript of analyst and investor call on the IRDAI consultation paper (call 24 Sep 2026) · NSE (company filing, nsearchives.nseindia.com) · Tier 1: company or exchange filing · 25 Sep 2026
- S30Shareholding pattern as of 30 Sep 2026 (XBRL) · NSE (company filing, nsearchives.nseindia.com) · Tier 1: company or exchange filing · 21 Oct 2026
- S31Shareholding pattern as of 30 Jun 2026 (XBRL) · NSE (company filing, nsearchives.nseindia.com) · Tier 1: company or exchange filing · 20 Jul 2026
- S32Shareholding pattern as of 31 Mar 2026 (XBRL) · NSE (company filing, nsearchives.nseindia.com) · Tier 1: company or exchange filing · 21 Apr 2026
- S33Shareholding pattern as of 31 Dec 2025 (XBRL) · NSE (company filing, nsearchives.nseindia.com) · Tier 1: company or exchange filing · 20 Jan 2026
- S34Shareholding pattern as of 30 Sep 2025 (XBRL) · NSE (company filing, nsearchives.nseindia.com) · Tier 1: company or exchange filing · 18 Oct 2025
- S35Shareholding pattern as of 30 Jun 2025 (XBRL) · NSE (company filing, nsearchives.nseindia.com) · Tier 1: company or exchange filing · 17 Jul 2025
- S36Shareholding pattern as of 31 Mar 2025 (XBRL) · NSE (company filing, nsearchives.nseindia.com) · Tier 1: company or exchange filing · 18 Apr 2025
- S37Shareholding pattern as of 31 Dec 2024 (XBRL) · NSE (company filing, nsearchives.nseindia.com) · Tier 1: company or exchange filing · 22 Jan 2025
- S38Shareholding pattern as of 30 Sep 2024 (XBRL) · NSE (company filing, nsearchives.nseindia.com) · Tier 1: company or exchange filing · 18 Oct 2024
- S39Shareholding pattern as of 30 Jun 2024 (XBRL) · NSE (company filing, nsearchives.nseindia.com) · Tier 1: company or exchange filing · 19 Jul 2024
- S40Shareholding pattern as of 31 Mar 2024 (XBRL) · NSE (company filing, nsearchives.nseindia.com) · Tier 1: company or exchange filing · 17 Apr 2024
- S41Shareholding pattern as of 31 Dec 2023 (XBRL) · NSE (company filing, nsearchives.nseindia.com) · Tier 1: company or exchange filing · 18 Jan 2024
- S42Red Herring Prospectus (25 Oct 2021), IPO of PB Fintech Limited · NSE (IPO offer documents, archives.nseindia.com) · Tier 1: company or exchange filing · 25 Oct 2021
- S43Basis of allotment and listing advertisement (IPO at Rs 980; trading from 15 Nov 2021) · NSE (company filing, nsearchives.nseindia.com) · Tier 1: company or exchange filing · 12 Nov 2021
- S44NSE historical price data (security-wise), POLICYBZR EQ, 1-11 Nov 2026 · NSE (historical price data) · Tier 1: company or exchange filing · 11 Nov 2026
- S45Reg 30: IRDAI order dated 4 Aug 2025 levying a Rs 5 crore penalty on Policybazaar · NSE (company filing, nsearchives.nseindia.com) · Tier 1: company or exchange filing · 5 Aug 2025
- S46Reg 30: IRDAI letter of advice and show cause notice (inspection Oct 2024), received 13 Aug 2026 · NSE (company filing, nsearchives.nseindia.com) · Tier 1: company or exchange filing · 14 Aug 2026
- S47Clarification on price movement: IRDAI consultation paper on the economics of insurance distribution · NSE (company filing, nsearchives.nseindia.com) · Tier 1: company or exchange filing · 27 Sep 2026
- S48Clarification on market rumour about the Chairman and CEO (17 Sep 2026) · NSE (company filing, nsearchives.nseindia.com) · Tier 1: company or exchange filing · 17 Sep 2026
- S50Reg 30: Benami Act adjudicating authority order on Paisabazaar (24 Mar 2026) · NSE (company filing, nsearchives.nseindia.com) · Tier 1: company or exchange filing · 27 Mar 2026
- S51Reg 30: CIT(A) order confirming income-tax disallowances at Paisabazaar (30 Apr 2026) · NSE (company filing, nsearchives.nseindia.com) · Tier 1: company or exchange filing · 1 May 2026
- S52Reg 30: SEBI settlement order (4 Mar 2025) in respect of the Chairman and CEO · NSE (company filing, nsearchives.nseindia.com) · Tier 1: company or exchange filing · 5 Mar 2025
- S53Reg 30: approval to invest up to Rs 696 crore in PB Healthcare Services (11 Mar 2025) · NSE (company filing, nsearchives.nseindia.com) · Tier 1: company or exchange filing · 11 Mar 2025
- S54Reg 30: Rs 539.4 crore invested in PB Healthcare Services (24 Apr 2025) · NSE (company filing, nsearchives.nseindia.com) · Tier 1: company or exchange filing · 24 Apr 2025
- S55Reg 30: RBI payment aggregator authorisation to PB Pay (6 Feb 2026) · NSE (company filing, nsearchives.nseindia.com) · Tier 1: company or exchange filing · 6 Feb 2026
- S56Clarification on news about a USD 1 billion fundraise (6 Feb 2026) · NSE (company filing, nsearchives.nseindia.com) · Tier 1: company or exchange filing · 6 Feb 2026
- S58Reg 30: change of Policybazaar CEO and Principal Officer (7 Apr 2026) · NSE (company filing, nsearchives.nseindia.com) · Tier 1: company or exchange filing · 7 Apr 2026
- S59Reg 30: IPO proceeds earmarked for overseas expansion utilised (31 Mar 2026) · NSE (company filing, nsearchives.nseindia.com) · Tier 1: company or exchange filing · 31 Mar 2026
- S61Reg 30: re-appointment of Yashish Dahiya and Alok Bansal for five years from 2026 · NSE (company filing, nsearchives.nseindia.com) · Tier 1: company or exchange filing · 27 Aug 2025
Changes to this page (v1 · 12 Nov 2026)
- v1 · 12 Nov 2026First version. (first version)
Numbers come only from tier 1 and tier 2 sources. Read how we research.
Disclaimer
For learning only. Cityfort is not a SEBI-registered adviser and does not recommend buying or selling any security. Prices shown are dated and may be out of date.
Investing in securities involves risk, including loss of capital. Before making any investment decision, do your own research and consider consulting a SEBI-registered investment adviser.
Cityfort, its owners and contributors may or may not hold securities of companies covered. Content is not an offer or solicitation to buy or sell any security.
Read the full disclaimerHide the full disclaimer
Cityfort publishes educational content that explains how listed companies work. Cityfort is not registered with the Securities and Exchange Board of India (SEBI) as an Investment Adviser or Research Analyst and does not provide investment advice, recommendations, ratings, price targets or any opinion on whether to buy, sell or hold any security.
All information is taken from publicly available sources, mainly company filings on BSE and NSE, which are listed on each page with dates. We work to keep it accurate and correct errors publicly, but we do not guarantee that it is complete, accurate or up to date. Any market price or price-based ratio shown is dated, may be out of date by the time you read it, and is included only to explain concepts.
Statements by company management are reported as statements, with their date and source; they are not our forecasts.